Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver Transplantation
This study has been terminated.
(Study is prematurely ended due to poor patient recruitment rate.)
Sponsor:
Fresenius Kabi
Information provided by:
Fresenius Kabi
ClinicalTrials.gov Identifier:
NCT00308100
First received: March 28, 2006
Last updated: January 14, 2009
Last verified: January 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | July 2008 |
| Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |